New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 13, 2014
07:37 EDTNSTGNanoString reports preliminary Q4 revenue about $10.1M, consensus $9.61M.
NanoString anticipates instrument revenue of approximately $5.3M for Q4, representing approximately 112% growth compared to $2.5M for 4Q12. The company's installed base of nCounter Analysis Systems stood at over 180 systems as of the end of 2013. Consumables revenue is anticipated to be approximately $4.4M in Q4, representing approximately 19% growth over the $3.7M reported for 4Q12.
News For NSTG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 20, 2015
07:21 EDTNSTGUBS to hold a conference
Subscribe for More Information
May 15, 2015
10:28 EDTNSTGMAC updates positive for NanoString, Myriad, Invitae, QIAGEN, says Leerink
Leerink said that coverage updates posted yesterday by Medicare Administrative Contractors were favorable for NanoString (NSTG), Myriad Genetics (MYGN), Invitae (NVTA) and QIAGEN (QGEN). The firm has Outperform ratings on NanoString and Invitae and Market Perform rating on the other two stocks listed.
09:00 EDTNSTGNanoString management to meet with Leerink
Meeting to be held in Boston on May 21 hosted by Leerink.
May 14, 2015
16:35 EDTNSTGNanoString announces favorable draft local coverage determination by Palmetto
Subscribe for More Information
May 12, 2015
07:19 EDTNSTGPAM50 included in St. Gallen International Breast Cancer Guidelines
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use